Lishan Su, PhD Investiture Program

More documents

Recommendations

Info

LISHAN SU, PHD of North Carolina-Chapel Hill. Lishan Su, PhD grew up in Qingdao, China, and received his BS in Microbiology from Shandong University, PhD in Virology from Harvard University, and did postdoctoral training in Immunology at Stanford University. Dr. Su then worked as a research scientist in a biotech company, focusing on HIV pathogenesis and testing blood stem cell-based HIV-1 gene therapy in HIV-infected patients. From 1996 to 2021, he was a faculty member in the Lineberger Comprehensive Cancer Center and Professor in the Department of Microbiology & Immunology at University For over two decades, Dr. Su has focused on studying several critical areas of immuno-pathology of human chronic virus infections, particularly on elucidating how HIV causes AIDS-related diseases. The Su laboratory studies how HIV-1 and HBV interact with human immune cells to cause diseases. His research team has focused on the plasmacytoid dendritic cell (pDC)-interferon axis in the pathogenesis and therapy of chronic HIV infection and Disease-Associated Macrophages (DAM)-hepatic stellate cells in HBV-induced liver diseases in humanized mice and in patients. The team has also started investigation of the pathways in tumor microenvironments (TME) and in cancer immune therapy. After joining The Institute of Human Virology at UMSOM, Dr. Su continued his research program to use HIV and HBV viruses as probes to dissect human immunity and inflammatory diseases, and to develop antibody and cell-based drugs targeting novel immune cells and signaling pathways to treat human inflammatory diseases including virus infection and cancer. He has also trained over 40 postdoc/ visiting scholars and 20 graduate students from 8 different countries. Dr. Su has served on grant review committees for US/European and Chinese funding agencies for over 20 years, and as associate editor or on editorial boards of several journals. For the past 20 years, Dr. Su has also interacted with US and international institutions, including providing advice and to evaluate progress to biomedical research institutes and centers. He has also received several awards over the years, including election as a Fellow of the American Association for the Advancement of Science in 2012, and the Charles Gordon Smith Endowed Professorship for HIV Research in 2021.
WELCOME Mary Pooton Associate Dean for Development University of Maryland School of Medicine Margaret M. McCarthy, PhD The James and Carolyn Frenkil Dean’s Professor and Chair, Department of Pharmacology Director, Program in Neuroscience University of Maryland School of Medicine REMARKS Mark T. Gladwin, MD Vice President for Medical Affairs, UM Baltimore John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine DONOR RECOGNITION Mark T. Gladwin, MD SPEAKERS Robert C. Gallo, MD The Homer and Martha Gudelsky Distinguished Professor of Medicine Co-Founder & Director, Institute of Human Virology (IHV) University of Maryland School of Medicine Mike McCune, MD, PhD Head, HIV Frontiers Initiatives Bill & Melinda Gates Foundation Yang Liu, PhD Chief Executive Officer & Chief Scientific Officer OncoC4 Inc. Mark Bonyhadi, PhD Senior Advisor Qiming Venture Partners USA MEDAL PRESENTATION Mark T. Gladwin, MD REMARKS Lishan Su, PhD The Charles Gordon Smith Professor for HIV Research CLOSING REMARKS Margaret M. McCarthy, PhD
Page 4 and 5: T he first endowed professorships w

Lishan Su, PhD Investiture Program

Create successful ePaper yourself

Delete template?

Save as template?